Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$6.72 - $16.07 $4,032 - $9,642
-600 Reduced 0.16%
381,537 $3.42 Million
Q1 2022

May 10, 2022

SELL
$11.88 - $23.4 $21,087 - $41,535
-1,775 Reduced 0.46%
382,137 $5.82 Million
Q4 2021

Feb 10, 2022

BUY
$21.08 - $38.51 $50,043 - $91,422
2,374 Added 0.62%
383,912 $8.76 Million
Q3 2021

Nov 10, 2021

BUY
$27.67 - $45.04 $1.73 Million - $2.82 Million
62,574 Added 19.62%
381,538 $13.2 Million
Q2 2021

Aug 12, 2021

BUY
$28.75 - $56.92 $2.81 Million - $5.56 Million
97,646 Added 44.12%
318,964 $10.5 Million
Q1 2021

May 13, 2021

BUY
$38.67 - $84.06 $8.56 Million - $18.6 Million
221,318 New
221,318 $11.1 Million

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $115M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Pier Capital, LLC Portfolio

Follow Pier Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.